IMMUTEP LTD-SP ADR (IMMP) Fundamental Analysis & Valuation

NASDAQ:IMMP • US45257L1089

Current stock price

0.4623 USD
-0.02 (-3.2%)
At close:
0.4607 USD
0 (-0.35%)
After Hours:

This IMMP fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. IMMP Profitability Analysis

1.1 Basic Checks

  • IMMP had negative earnings in the past year.
  • In the past year IMMP has reported a negative cash flow from operations.
  • IMMP had negative earnings in each of the past 5 years.
  • In the past 5 years IMMP always reported negative operating cash flow.
IMMP Yearly Net Income VS EBIT VS OCF VS FCFIMMP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -20M -40M -60M

1.2 Ratios

  • IMMP has a Return On Assets (-57.01%) which is in line with its industry peers.
  • IMMP's Return On Equity of -84.85% is in line compared to the rest of the industry. IMMP outperforms 47.96% of its industry peers.
Industry RankSector Rank
ROA -57.01%
ROE -84.85%
ROIC N/A
ROA(3y)-29.13%
ROA(5y)-31.07%
ROE(3y)-31.51%
ROE(5y)-33.92%
ROIC(3y)N/A
ROIC(5y)N/A
IMMP Yearly ROA, ROE, ROICIMMP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50 -100 -150

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for IMMP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IMMP Yearly Profit, Operating, Gross MarginsIMMP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -20K -40K -60K -80K -100K

3

2. IMMP Health Analysis

2.1 Basic Checks

  • IMMP does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, IMMP has less shares outstanding
  • IMMP has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, IMMP has a worse debt to assets ratio.
IMMP Yearly Shares OutstandingIMMP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M
IMMP Yearly Total Debt VS Total AssetsIMMP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

2.2 Solvency

  • Based on the Altman-Z score of -4.40, we must say that IMMP is in the distress zone and has some risk of bankruptcy.
  • IMMP has a worse Altman-Z score (-4.40) than 61.36% of its industry peers.
  • IMMP has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of IMMP (0.01) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z -4.4
ROIC/WACCN/A
WACC9.9%
IMMP Yearly LT Debt VS Equity VS FCFIMMP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 2.97 indicates that IMMP has no problem at all paying its short term obligations.
  • IMMP has a worse Current ratio (2.97) than 63.50% of its industry peers.
  • A Quick Ratio of 2.97 indicates that IMMP has no problem at all paying its short term obligations.
  • IMMP has a worse Quick ratio (2.97) than 61.55% of its industry peers.
Industry RankSector Rank
Current Ratio 2.97
Quick Ratio 2.97
IMMP Yearly Current Assets VS Current LiabilitesIMMP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

5

3. IMMP Growth Analysis

3.1 Past

  • IMMP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -69.70%.
  • The Revenue has grown by 7581.23% in the past year. This is a very strong growth!
  • IMMP shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -66.35% yearly.
EPS 1Y (TTM)-69.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)7581.23%
Revenue growth 3Y-38.18%
Revenue growth 5Y-66.35%
Sales Q2Q%6.31%

3.2 Future

  • IMMP is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 28.04% yearly.
  • IMMP is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 130.58% yearly.
EPS Next Y-2.97%
EPS Next 2Y6.21%
EPS Next 3Y-0.66%
EPS Next 5Y28.04%
Revenue Next Year375.9%
Revenue Next 2Y-4.78%
Revenue Next 3Y-0.79%
Revenue Next 5Y130.58%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
IMMP Yearly Revenue VS EstimatesIMMP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1B 2B 3B
IMMP Yearly EPS VS EstimatesIMMP Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 2 -2 4 -4 -6

0

4. IMMP Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for IMMP. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for IMMP. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IMMP Price Earnings VS Forward Price EarningsIMMP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IMMP Per share dataIMMP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.21%
EPS Next 3Y-0.66%

0

5. IMMP Dividend Analysis

5.1 Amount

  • IMMP does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

IMMP Fundamentals: All Metrics, Ratios and Statistics

IMMUTEP LTD-SP ADR

NASDAQ:IMMP (4/30/2026, 8:00:03 PM)

After market: 0.4607 0 (-0.35%)

0.4623

-0.02 (-3.2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Industry StrengthN/A
Industry GrowthN/A
Earnings (Last)01-29
Earnings (Next)07-29
Inst Owners60.34%
Inst Owner Change-0.12%
Ins Owners2.56%
Ins Owner Change0%
Market Cap68.05M
Revenue(TTM)4.13M
Net Income(TTM)-83.92M
Analysts72.5
Price Target7.4 (1500.69%)
Short Float %0.87%
Short Ratio0.07
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)107.85%
PT rev (3m)124.49%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)22.84%
EPS NY rev (3m)25.79%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)12.91%
Revenue NY rev (3m)38.88%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 22.99
P/FCF N/A
P/OCF N/A
P/B 0.96
P/tB 1.02
EV/EBITDA N/A
EPS(TTM)-0.4
EYN/A
EPS(NY)-0.26
Fwd EYN/A
FCF(TTM)-0.3
FCFYN/A
OCF(TTM)-0.3
OCFYN/A
SpS0.02
BVpS0.48
TBVpS0.45
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -57.01%
ROE -84.85%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-29.13%
ROA(5y)-31.07%
ROE(3y)-31.51%
ROE(5y)-33.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 3.07%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.97
Quick Ratio 2.97
Altman-Z -4.4
F-Score3
WACC9.9%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-69.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y-2.97%
EPS Next 2Y6.21%
EPS Next 3Y-0.66%
EPS Next 5Y28.04%
Revenue 1Y (TTM)7581.23%
Revenue growth 3Y-38.18%
Revenue growth 5Y-66.35%
Sales Q2Q%6.31%
Revenue Next Year375.9%
Revenue Next 2Y-4.78%
Revenue Next 3Y-0.79%
Revenue Next 5Y130.58%
EBIT growth 1Y-62.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year13.86%
EBIT Next 3Y-3.13%
EBIT Next 5Y32.37%
FCF growth 1Y-47.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-48.67%
OCF growth 3YN/A
OCF growth 5YN/A

IMMUTEP LTD-SP ADR / IMMP Fundamental Analysis FAQ

What is the ChartMill fundamental rating of IMMUTEP LTD-SP ADR (IMMP) stock?

ChartMill assigns a fundamental rating of 2 / 10 to IMMP.


What is the valuation status of IMMUTEP LTD-SP ADR (IMMP) stock?

ChartMill assigns a valuation rating of 0 / 10 to IMMUTEP LTD-SP ADR (IMMP). This can be considered as Overvalued.


Can you provide the profitability details for IMMUTEP LTD-SP ADR?

IMMUTEP LTD-SP ADR (IMMP) has a profitability rating of 1 / 10.